First Presentations of Phase 3 Data for Bimekizumab Across the Full Spectrum of Axial Spondyloarthritis to be Shared at EULAR 2022

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

United States ,Denmark ,Copenhagen ,Køavn ,Brussels ,Bruxelles Capitale ,Belgium ,Smyrna ,Izmir ,Turkey ,Emmanuel Caeymaex ,Eimear Obrien ,Antje Witte ,Immunology Solutions ,European Congress ,Brand Communications ,Twitter ,Ucb Inc ,Drug Administration ,Assessment Of Spondyloarthritis International Society ,Corporate Communications ,Source Ucb Inc ,Executive Vice President ,Spondyloarthritis International Society ,Euronext Brussels ,Covid 19 ,Politics ,Technology ,Health ,Arthritis ,Pr Newswire ,Data Privacy ,